Studying heart failure with preserved ejection fraction in people with COPD
Observes heart function and outcomes in adults aged 50 to 70 with COPD.
Plain-language title generated from the registry record
Registry title: Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis
Key facts
- Where
- Kazan' and Moscow, RussiaSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 50 to 70 with a confirmed COPD diagnosis who are in hospital because of COPD. It studies heart failure with preserved ejection fraction in these patients.
- Age
- 50 to 70 years
- Sex
- All sexes can join.
- Disease stage
- Confirmed COPD, hospitalized because of COPD.
Main reasons for not taking part
- Not a citizen of the Russian Federation
- Refusal to take part in the study
- Any other chronic disease that affects the outlook, in an acute or decompensated stage
- Mental disorders
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 70 years old?
Source: NCT07375433, who can take part
Where in Russia
- Kazan State Medical UniversityKazan', RussiaTaking people
- National Medical Research Center for Therapy and Preventive MedicineMoscow, RussiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Medical Research Center for Therapy and Preventive Medicine
- Trial code
- NCT07375433
- Record updated
- 10 February 2026
- Original description
Study aim is comparison of heart failire with preserved ejection fraction (HFpEF) detection rate in patients with Сhronic Obstructive Pulmonary Disease (COPD) and the clinical course and prognosis in patients with COPD depending on HFpEF presence.Read full original descriptionShow less
Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis
Study aim is comparison of heart failire with preserved ejection fraction (HFpEF) detection rate in patients with Сhronic Obstructive Pulmonary Disease (COPD) and the clinical course and prognosis in patients with COPD depending on HFpEF presence.
Inclusion: Verified diagnosis of COPD; Patients hospitalized with COPD; Citizenship of the Russian Federation; Patients aged 50 to 70 years; Patient consent to participate in the study.
Exclusion: Any chronic diseases, other than COPD, that affect the prognosis, in the acute and/or decompensated stage; Mental disorders; Lack of Russian Federaion citizenship; Patient's refusal to participate in the study.